Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
A long-term, open-label, non-comparative safety and efficacy study of CD07805/47 gel 0.5%
once daily in subjects with moderate to severe facial erythema associated with rosacea.